The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Prospective Evaluation of a Commercially Available Hydrogel Spacer
Official Title: Clinical Protocol for the Prospective Evaluation of a Commercially Available Hydrogel Spacer
Study ID: NCT05323747
Brief Summary: Dosimetry efficacy evaluation of the hydrogel spacer
Detailed Description: Single arm study for evaluation of dosimetry following use of a commercially available hydrogel spacer implanted in 20 males undergoing radiotherapy to treat prostate cancer. Study will utilize pre and post gel insertion CT images to determine the endpoints.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Western Radiation Oncology, Campbell, California, United States
Northern Nevada Radiation Oncology, Reno, Nevada, United States